Detalhe da pesquisa
1.
Integrated multi-omic analysis identifies fatty acid binding protein 4 as a biomarker and therapeutic target of ischemia-reperfusion injury in steatotic liver transplantation.
Cell Mol Life Sci
; 81(1): 83, 2024 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38341383
2.
Downregulation of N4-acetylcytidine modification in myeloid cells attenuates immunotherapy and exacerbates hepatocellular carcinoma progression.
Br J Cancer
; 130(2): 201-212, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38040817
3.
SULT2B1-CS-DOCK2 axis regulates effector T-cell exhaustion in HCC microenvironment.
Hepatology
; 78(4): 1064-1078, 2023 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36626623
4.
Ten-eleven translocation-2-mediated macrophage activation promotes liver regeneration.
Cell Commun Signal
; 22(1): 95, 2024 02 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38308318
5.
Arming CAR-T cells with cytokines and more: Innovations in the fourth-generation CAR-T development.
Mol Ther
; 31(11): 3146-3162, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37803832
6.
Peritoneal Gene Transfection of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand for Tumor Surveillance and Prophylaxis.
Nano Lett
; 23(17): 7859-7868, 2023 09 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37433066
7.
A mixed blessing for liver transplantation patients - Rapamycin.
Hepatobiliary Pancreat Dis Int
; 22(1): 14-21, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36328894
8.
TNFR2 is a potent prognostic biomarker for post-transplant lung metastasis in patients with hepatocellular carcinoma.
Chin J Cancer Res
; 35(1): 66-80, 2023 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36910852
9.
E2F7 promotes mammalian target of rapamycin inhibitor resistance in hepatocellular carcinoma after liver transplantation.
Am J Transplant
; 22(10): 2323-2336, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35729702
10.
Patient-derived xenograft models in hepatopancreatobiliary cancer.
Cancer Cell Int
; 22(1): 41, 2022 Jan 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35090441
11.
Cellular crosstalk during liver regeneration: unity in diversity.
Cell Commun Signal
; 20(1): 117, 2022 08 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35941604
12.
Efficacy and safety of sirolimus early conversion protocol in liver transplant patients with hepatocellular carcinoma: A single-arm, multicenter, prospective study.
Hepatobiliary Pancreat Dis Int
; 21(2): 106-112, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34583911
13.
Key factors and potential drug combinations of nonalcoholic steatohepatitis: Bioinformatic analysis and experimental validation-based study.
Hepatobiliary Pancreat Dis Int
; 20(5): 433-451, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34233850
14.
Molecular phenotypes reveal heterogeneous engraftments of patient-derived hepatocellular carcinoma xenografts.
Chin J Cancer Res
; 33(4): 470-479, 2021 Aug 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-34584372
15.
Systematic review: risk prediction models for recurrence of hepatocellular carcinoma after liver transplantation.
Transpl Int
; 33(7): 697-712, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31985857
16.
Glutamine synthetase promotes tumor invasion in hepatocellular carcinoma through mediating epithelial-mesenchymal transition.
Hepatol Res
; 50(2): 246-257, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31652385
17.
Ubiquitin-Specific Protease 22/Silent Information Regulator 1 Axis Plays a Pivotal Role in the Prognosis and 5-Fluorouracil Resistance in Hepatocellular Carcinoma.
Dig Dis Sci
; 65(4): 1064-1073, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31587155
18.
CC motif chemokine ligand 16 inhibits the progression of liver cirrhosis via inactivating hepatic stellate cells.
Hepatobiliary Pancreat Dis Int
; 19(5): 440-448, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31948840
19.
Hangzhou criteria as downstaging criteria in hepatocellular carcinoma before liver transplantation: A multicenter study from China.
Hepatobiliary Pancreat Dis Int
; 19(4): 349-357, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32622826
20.
lncRNA DRHC inhibits proliferation and invasion in hepatocellular carcinoma via c-Myb-regulated MEK/ERK signaling.
Mol Carcinog
; 58(3): 366-375, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30362626